Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.27USD
9:00pm BST
Change (% chg)

$-0.18 (-2.13%)
Prev Close
$8.45
Open
$8.48
Day's High
$8.53
Day's Low
$8.26
Volume
16,990
Avg. Vol
55,825
52-wk High
$11.44
52-wk Low
$6.20

Siegel, Jamie 

Ms. Jamie Siegel is Head - Clinical Development of the Company. Ms. Ellen Siegel, M.D., brings to Catalyst over 30 years of clinical, clinical laboratory, and program development experience in the hematology field, particularly in hemophilia, with the last ten years in government and industry settings. Jamie was director of the Hemophilia and Thrombosis Center, Cardeza Foundation Special Hemostasis Laboratory, and associate professor of medicine at Thomas Jefferson University. She was co-director of the Medical Advisory Board for the Hemophilia Federation of America and has received numerous humanitarian awards from hemophilia patient advocacy groups. Before joining Catalyst, Jamie held a number of high-level positions, including medical director at Novo Nordisk and global clinical leader at Bayer where she worked on two major hemophilia programs, and was Chief, Thrombosis and Hemostasis branch at the National Institutes of Health. She has overseen numerous clinical trials and has authored over 35 hematology publications, including almost 20 peer-reviewed papers, seven peer-reviewed review articles, and seven book chapters. Jamie received her medical degree from the Medical College of Pennsylvania and holds a bachelor of arts from Lehigh University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --